Press Release – New York, NY – July 23, 2020 – Sichenzia Ross Ference LLP today announced that it represented Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical company focused on …
Sichenzia Ross Ference LLP Represents INmune Bio, Inc. in $21.74 Million Public Offering of Common Stock
Press Release – New York, NY – July 17, 2020 – Sichenzia Ross Ference LLP announced that it represented INmune Bio Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing …
Sichenzia Ross Ference LLP Represents Equillium, Inc. in $150 Million At-The-Market Offering Through Jeffries LLC
Press Release – New York, NY – July 16, 2020 – Sichenzia Ross Ference LLP announced that it represented Equillium, Inc. (NASDAQ: “EQ”), a clinical-stage biotechnology company developing itolizumab to …
Sichenzia Ross Ference LLP Represents H.C. Wainwright as Sales Agent in $7 Million At-The-Market Offering of BioPath Holdings
Press Release – New York, NY – July 15, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC, as sales agent in an At-The-Market Offering (“ATM”) of …
Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6.43 Million Public Offering of Common Stock
Press Release – New York, NY – July 7, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating …
Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6 Million Public Offering of Common Stock
Press Release – New York, NY – June 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating …
